Categories: India

UPDATE 1-J&J strikes $2.2 billion buyout deal for eye disease biotech Ollin Biosciences

(Adds details in paragraphs 2-4) Nov 16 (Reuters) – Johnson & Johnson said on Monday it had agreed to buy Texas-based biotech Ollin Biosciences, expanding its pipeline of eye disease therapies.

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

Tyson Foods forecasts steeper-than-expected annual revenue decline

Nov 16 (Reuters) - Tyson Foods forecast a steeper-than-expected annual revenue decline on Monday as…

2 minutes ago

Singapore, US agree to keep discussing Megaspeed as scrutiny of Nvidia scandal widens

By Jun Yuan Yong and Eduardo Baptista Nov 16 (Reuters) - Singapore's government said on…

3 minutes ago

Batman x Samsonite: Iconic DC Super Hero, Reimagined Through the Lens of Modern Travel

Mumbai (Maharashtra) [India], November 16: Samsonite, the global leader in travel, luggage and mobility solutions,…

10 minutes ago

BRIEF-Zhuhai Kles Technology's Board Elects Chairman

Nov 16 (Reuters) - Zhuhai Kles Technology Co Ltd : * SAYS BOARD ELECTED YU…

11 minutes ago

Dollar extends rally, yen looks past soft Japan GDP data

By Javi West Larrañaga and Gregor Stuart Hunter GDANSK, Nov 16 (Reuters) - The dollar…

13 minutes ago

Trump's Nvidia stake grew to as much as $62 million, Washington Post reports

Nov 16 (Reuters) - US President Donald Trump's reported trades this year suggest he held…

14 minutes ago